iifl-logo-icon 1

Colinz Laboratories Ltd Share Price

60.51
(-4.99%)
Jul 19, 2024|09:55:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open60.51
  • Day's High60.51
  • 52 Wk High84.4
  • Prev. Close63.69
  • Day's Low60.51
  • 52 Wk Low33.35
  • Turnover (lac)0.56
  • P/E60.08
  • Face Value10
  • Book Value24.06
  • EPS1.06
  • Mkt. Cap (Cr.)27.66
  • Div. Yield0
No Records Found

Colinz Laboratories Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

60.51

Prev. Close

63.69

Turnover(Lac.)

0.56

Day's High

60.51

Day's Low

60.51

52 Week's High

84.4

52 Week's Low

33.35

Book Value

24.06

Face Value

10

Mkt Cap (₹ Cr.)

27.66

P/E

60.08

EPS

1.06

Divi. Yield

0

Colinz Laboratories Ltd Corporate Action

4 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

31 Jul 2023

12:00 AM

BookCloser

arrow

31 Jul 2023

12:00 AM

AGM

Announcement Date: 31 Jul, 2023

arrow

Colinz Laboratories Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Colinz Laboratories Ltd SHAREHOLDING SNAPSHOT

20 Jul, 2024|10:28 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 66.00%

Foreign: 0.00%

Indian: 66.00%

Non-Promoter- 33.99%

Institutions: 0.00%

Non-Institutions: 33.99%

Custodian: 0.00%

Share Price

Colinz Laboratories Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

2.52

3.55

3.55

3.54

Preference Capital

0

0

0

0

Reserves

5.62

4.14

3.75

3.29

Net Worth

8.14

7.69

7.3

6.83

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

6.11

7.53

7.95

8.04

yoy growth (%)

-18.88

-5.29

-1.1

-0.59

Raw materials

-2.18

-2.74

-2.7

-2.94

As % of sales

35.72

36.4

33.96

36.58

Employee costs

-2.5

-3.52

-3.39

-3.13

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

0.24

0.17

0.15

0.11

Depreciation

-0.19

-0.19

-0.22

-0.26

Tax paid

-0.03

-0.04

0.07

0.02

Working capital

1.08

0.76

-0.11

-0.08

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-18.88

-5.29

-1.1

-0.59

Op profit growth

9.63

-15.59

-12.37

-9.23

EBIT growth

36.58

3.28

-0.36

-11.69

Net profit growth

59.12

-43.44

63.45

49.18

View Ratios

No Record found

Colinz Laboratories Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,593.65

125.293,82,370.02867.60.855,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,582.3

77.221,21,645.675310.652,259507.93

Cipla Ltd

CIPLA

1,506.05

32.741,21,616.251,038.40.563,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,185.3

34.71,19,268.911,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,665.1

25.951,11,193.661,034.80.65,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Colinz Laboratories Ltd

Management

Register Office

Registrar Office

Director & Company Secretary

L S Mani

Whole-time Director

N K Menon

Independent Director

Vasant K Bhat

Independent Director

A Krishna Kumar

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Colinz Laboratories Limited, was incorporated as a Private Limited Company in 1986. The Company got converted into Public Limited Company in 1995, which however started their manufacturing and marketing activities in 1995. The Company manufactures a wide variety of pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams etc. The Company is having certain specialized products for Gynaecology, Cardiology, Gastroentrology etc. Since, the Company falls under the MSME sector, it established reputation as a quality supplier of medicines in the domestic market, wherever the Company has operation.Apart from this, the Company has a WHO compliant plant at Sinnar. Apart from a modern plant, it has its own well equipped quality control laboratory. The technical team is headed by a Vice President (works), Plant Manager & Production Manager etc. They are highly qualified and FDA approved expert staff with over two decades of experience in manufacturing and development of a number of products for various therapeutic segments. The Companys products are enjoying a good Brand image, particularly among gynaecologists. The Company has potential to grow considering the fact that it is yet to open up its marketing operations in many states of the country, which is kept on hold due to general economic situation.
Read More

Company FAQs

What is the Colinz Laboratories Ltd share price today?

Down Arrow

The Colinz Laboratories Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹60.51 today.

What is the Market Cap of Colinz Laboratories Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Colinz Laboratories Ltd is ₹27.66 Cr. as of 19 Jul ‘24

What is the PE and PB ratio of Colinz Laboratories Ltd?

Down Arrow

The PE and PB ratios of Colinz Laboratories Ltd is 60.08 and 2.65 as of 19 Jul ‘24

What is the 52 Week High and Low of Colinz Laboratories Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Colinz Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Colinz Laboratories Ltd is ₹33.35 and ₹84.4 as of 19 Jul ‘24

What is the CAGR of Colinz Laboratories Ltd?

Down Arrow

Colinz Laboratories Ltd's CAGR for 5 Years at 48.94%, 3 Years at 41.56%, 1 Year at 76.18%, 6 Month at 51.75%, 3 Month at 60.23% and 1 Month at 49.51%.

What is the shareholding pattern of Colinz Laboratories Ltd?

Down Arrow

The shareholding pattern of Colinz Laboratories Ltd is as follows:
Promoters - 66.00 %
Institutions - 0.00 %
Public - 34.00 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.